阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段

美港电讯10-30

【阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段】金十数据10月30日讯，10月29日，阳光诺和宣布：公司与北京艺妙神州医药科技有限公司及其全资子公司厦门再妙生物科技有限公司合作开发的用于治疗系统性红斑狼疮（SystemicLupusErythematosus,SLE）的新一代CAR-T药物ZM001注射液（简称“ZM001”），获得国家药品监督管理局颁发的《药物...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2479184562?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-30 10:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479184562","market":"us","top_or_hot":-1,"title":"阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段","media":"美港电讯","content":"<div>\n<p>【阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段】金十数据10月30日讯，10月29日，阳光诺和宣布：公司与北京艺妙神州医药科技有限公司及其全资子公司厦门再妙生物科技有限公司合作开发的用于治疗系统性红斑狼疮（SystemicLupusErythematosus,SLE）的新一代CAR-T药物ZM001注射液（简称“ZM001”），获得国家药品监督管理局颁发的《药物...</p>\n\n<a href=\"https://www.ushknews.com/\">网页链接</a>\n\n</div>\n","source":"live_meigang","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-30 10:39 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.ushknews.com/><strong>美港电讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段】金十数据10月30日讯，10月29日，阳光诺和宣布：公司与北京艺妙神州医药科技有限公司及其全资子公司厦门再妙生物科技有限公司合作开发的用于治疗系统性红斑狼疮（SystemicLupusErythematosus,SLE）的新一代CAR-T药物ZM001注射液（简称“ZM001”），获得国家药品监督管理局颁发的《药物...</p>\n\n<a href=\"https://www.ushknews.com/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4022","symbol_name":"陆运","start_time":0,"source_url":"https://www.ushknews.com/","article_id":"2479184562","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479184562","pubTimestamp":1730255969,"sourceInfo":{"source_id":"live_meigang","name":"美港电讯"},"weMediaInfo":null,"summary":"【阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段】金十数据10月30日讯，10月29日，阳光诺和宣布：公司与北京艺妙神州医药科技有限公司及其全资子公司厦门再妙生物科技有限","collect":0,"end_time":0,"defaultTopTitle":"ushknews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159837":"生物科技","159938":"医药","159992":"创新药","688621":"阳光诺和","BK4022":"陆运","BK4230":"旅客陆运","BK4077":"互动媒体与服务","BK1141":"生命科学工具和服务","BK1515":"抗疫概念","BK1161":"生物科技","BK1583":"高瓴概念","BK1574":"生物医药B类股","09939":"开拓药业-B","BK0216":"研究试验","BK1576":"医药外包概念","03347":"泰格医药","06978":"永泰生物-B","SLE":"Super League Gaming Inc.","CAR":"安飞士"},"translate_title":"The CAR-T therapy jointly developed by Sunshine Novo and Yimiao Shenzhou was approved to enter the clinical trial stage of systemic lupus erythematosus","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159837":1,"159938":1,"159992":1,"688621":1,"06978":1,"SLE":1,"CAR":1,"09939":1,"03347":1},"content_text":"【阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段】金十数据10月30日讯，10月29日，阳光诺和宣布：公司与北京艺妙神州医药科技有限公司及其全资子公司厦门再妙生物科技有限公司合作开发的用于治疗系统性红斑狼疮（SystemicLupusErythematosus,SLE）的新一代CAR-T药物ZM001注射液（简称“ZM001”），获得国家药品监督管理局颁发的《药物临床试验批准通知书》。标志着阳光诺和正式进入生物创新药领域，在CAR-T细胞治疗自身免疫性疾病领域取得的重大突破。","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479184562"}